Seth Toback

Seth Toback, MD, MMM has a breadth of experience in the medical field, with a focus on clinical development and medical affairs. Seth is currently serving as the Senior Vice President of Global Medical Affairs at Novavax Inc, responsible for building and leading the medical affairs department. Prior to this, they held the position of Vice President of Clinical Development at Novavax, where they played a key role in the successful phase 3 trial of their Covid-19 vaccine.

Before joining Novavax, Dr. Toback held positions at various pharmaceutical and biotechnology companies, including bioMérieux, United Therapeutics, PRA Health Sciences, Gilead Sciences, and AstraZeneca LP US. In these roles, they demonstrated expertise in clinical development, managing clinical trials, and providing medical oversight.

Dr. Toback also has experience in pediatric medicine, having worked as a Clinical Pediatrician at Loudoun Medical Group and as the Medical Director and Urgent Care Physician at MedExpress Urgent Care.

Throughout their career, Dr. Toback has contributed to the medical field through their involvement in professional organizations such as the American Academy of Pediatrics, where they served on executive committees related to practice management and therapeutics and technology. Seth has also been involved in steering committees focused on allergy and anaphylaxis at Dey Laboratories Inc.

In summary, Seth Toback, MD, MMM is a highly accomplished medical professional with extensive experience in clinical development, medical affairs, and pediatric medicine.

Seth Toback, MD, MMM obtained their Doctor of Medicine (MD) degree from Tufts University School of Medicine in the years 1993-1997. Seth then pursued a Master of Medical Management degree from Carnegie Mellon University between 2007 and 2009, specializing in Business Administration and Management. Prior to their advanced degrees, Toback completed their Bachelor of Science (BS) in Physiology from McGill University from 1989 to 1993. Additionally, they underwent Residency in Pediatrics, earning Board Certification, at Children's Hospital of Pittsburgh from 1997 to 2000.